The governing Board of the California Institute for Regenerative Medicine has approved a trio of awards, totaling approximately $4 million, to University of California San Diego School of Medicine researchers to advance studies of new stem cell-based treatments for multiple types of cancer and amyotrophic lateral sclerosis.
[UC San Diego Health]
7992332
{7992332:nan}
apa
50
1
166254
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
